ACADIA PHARMACEUTICALS INC (ACAD) Net margin 2016–2025
ACADIA PHARMACEUTICALS INC (ACAD) net profit margin by fiscal year — reported net income divided by reported revenue.
36.5%FY2025 · since FY2016: -1565.9% → 36.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 36.5% | +12.9 pp |
| FY2024 | 23.6% | +32.0 pp |
| FY2023 | -8.4% | +33.0 pp |
| FY2022 | -41.4% | -6.7 pp |
| FY2021 | -34.7% | +29.0 pp |
| FY2020 | -63.7% | +5.6 pp |
| FY2019 | -69.4% | +40.2 pp |
| FY2018 | -109.6% | +122.2 pp |
| FY2017 | -231.7% | +1334.2 pp |
| FY2016 | -1565.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice